-
261
Insulin Resistance Associated with Plasma Xanthine Oxidoreductase Activity Independent of Visceral Adiposity and Adiponectin Level: MedCity21 Health Examination Registry
Published 2019-01-01“…Higher levels of uric acid production have been reported in individuals with visceral fat obesity, and obesity is known to enhance xanthine oxidoreductase (XOR) activity, although the precise mechanism remains unclear. …”
Get full text
Article -
262
-
263
-
264
Simultaneous Determination of Uric Acid and Xanthine Using a Poly(Methylene Blue) and Electrochemically Reduced Graphene Oxide Composite Film Modified Electrode
Published 2014-01-01“…Poly(methylene blue) and electrochemically reduced graphene oxide composite film modified electrode (PMB-ERGO/GCE) was successfully fabricated by electropolymerization and was used for simultaneous determination of uric acid (UA) and xanthine (Xa). Based on the excellent electrocatalytic activity of PMB-ERGO/GCE, the electrochemical behaviors of UA and Xa were studied by cyclic voltammetry (CV) and square wave voltammetry (SWV). …”
Get full text
Article -
265
α-Amyrin and β-Amyrin Isolated from <i>Celastrus hindsii</i> Leaves and Their Antioxidant, Anti-Xanthine Oxidase, and Anti-Tyrosinase Potentials
Published 2021-11-01“…The mixture exhibited a high potential for preventing gout by inhibiting a relevant key enzyme, xanthine oxidase (XO) (IC<sub>50</sub> = 258.22 µg/mL). …”
Get full text
Article -
266
A Study of the Interaction between Xanthine Oxidase and Its Inhibitors from <i>Chrysanthemum morifolium</i> Using Computational Simulation and Multispectroscopic Methods
Published 2023-01-01“…The current therapeutic approach for gout is through the inhibition of the xanthine oxidase (XO) enzyme. Allopurinol, a clinically used XO inhibitor, causes many side effects. …”
Get full text
Article -
267
-
268
Effects of early aminophylline therapy on clinical outcomes in premature infants
Published 2023-05-01Subjects: Get full text
Article -
269
Preventive Effects of Fucoidan and Fucoxanthin on Hyperuricemic Rats Induced by Potassium Oxonate
Published 2019-06-01Subjects: Get full text
Article -
270
-
271
-
272
Formulation Development of Fast Dissolving Microneedles Loaded with Cubosomes of Febuxostat: In Vitro and In Vivo Evaluation
Published 2023-01-01Subjects: Get full text
Article -
273
Targeting Liver <i>Xor</i> by GalNAc-siRNA Is an Effective Strategy for Hyperuricemia Therapy
Published 2024-07-01Subjects: Get full text
Article -
274
Effects and Mechanism of Akkermansia muciniphila on Serum Uric Acid and Tissue Inflammation in Hyperuricemic Mice
Published 2023-03-01Subjects: “…akkermansia?muciniphila; xanthine oxidase; inflammatory response…”
Get full text
Article -
275
Theobromine for treatment of uric acid stones and other diseases
Published 2024-11-01Subjects: Get full text
Article -
276
Molybdenum Cofactor Biology and Disorders Related to Its Deficiency; A Review Study
Published 2019-08-01Subjects: Get full text
Article -
277
Delayed hypersensitivity reaction to allopurinol: A case report
Published 2023-02-01Subjects: Get full text
Article -
278
Available treatment options for hyperuricemic patients
Published 2021-12-01Subjects: Get full text
Article -
279
-
280
Hydroxysafflor Yellow A Inhibits LPS-Induced NLRP3 Inflammasome Activation via Binding to Xanthine Oxidase in Mouse RAW264.7 Macrophages
Published 2016-01-01“…In this study, we predicted the potential interaction between HSYA and xanthine oxidase (XO) via PharmMapper inverse docking and confirmed the binding inhibition via inhibitory test (IC50 = 40.04 μM). …”
Get full text
Article